ClinicalTrials.gg
CompletedNCT03399617Updated Mar 9, 2022

SPOON: Sustained Program for Improving Nutrition - Guatemala

An interventional study of Micronutrient Powders and SPOON behavioral change strategy in Exclusive Breast Feeding, Feeding Patterns and Stunting, sponsored by Inter-American Development Bank. Completed at 1 site in Guatemala. Open to participants aged Up to 3 Months, including healthy volunteers. Per ClinicalTrials.gov, last updated 2022-03-09.

Sponsored by Inter-American Development Bank · Not applicable, Interventional, and Prevention

Phase
Not applicable
Study type
Interventional
Enrollment
1,280
Allocation
Randomized
Ages
Up to 3 Months
Sex
All
01

Study summary

The primary goal of this study is to assess the impact of an innovative strategy to prevent undernutrition and obesity in early childhood in children 0-24 months in Guatemala. This study is designed to evaluate the impact of promoting adequate infant an young child feeding practices and the use of SQ-LNS (Small Quantity Lipid-Based Nutrient Supplements) on the nutritional status of infants and young children. The study will be conducted in Baja Verapaz, Guatemala in conjunction with Fundazucar, Guatemala.

Read the detailed description

SPOON Guatemala is an innovative strategy to prevent undernutrition and obesity in children aged 0-24 months living in high-poverty areas of Guatemala. SPOON focuses on improving feeding practices for infant and young children, including exclusive breastfeeding, and promote the use of home-fortification with peanut-based SQ-LNS (small quantity lipid-based nutrient supplements) through a novel behavior change strategy.

The study will recruit children between 0 and 3 months of age as well as pregnant women in the third trimester. Mothers or caregivers of eligible children will be invited to participate and a consent form obtain. Participation will start at 0-6 months and the intervention will last until children are 24 months. Participants will be randomly assigned at the community level to one of two groups: a control group and a treatment group. Participants in the control group will receive the standard services provided by their local health clinics in addition to a supply of micronutrient powders from 6-24 months of age, according to the national protocol. Participants in the treatment group will be randomly assigned at an individual level to receive two different interventions:

Treatment 1: This group will receive SQ-LNS supplement from 6-24 months and an innovative behavioral change strategy designed using ethnographic and marketing methods to promote adequate infant and young child feeding practices and the use of SQ-LNS. The strategy will be delivered to mothers or caregivers through individual home-visits, group sessions, and community mobilization activities.

Treatment 2. This group will receive micronutrient powders from 6-24 months and an innovative behavioral change strategy designed using ethnographic and marketing methods to promote adequate infant and young child feeding practices and the use of SQ-LNS. The strategy will be delivered to mothers or caregivers through individual home-visits, group sessions, and community mobilization activities.

A sample size of 500 children per group has been calculate to detect a minimum effect size of 0.2 with 95% level of significance and a 80% power for use of SQ-LNS. Additionally, a sample size of 40 communities and 500 children per group has been calculated to detect a minimum detectable effect size of 0.32 for communication.

Main outcomes include infant and young child feeding practices, height, weight, hemoglobin, prevalence of anemia, prevalence of stunting, prevalence of obesity, and weight gain rate. A baseline and final survey will be conducted to collect data for these variables, as well as sociodemographic information. Impact estimation will be done comparing the average results and the distribution of indicators between the treatment and control group. Differences of simple means and regression models including co-variables of the child's age and sex, and characteristics of the primary caregiver and household will be estimated. In addition to potential changes in indicator averages, changes in the distribution of variables will be explored under the hypothesis that the intervention might not only improve average value for a given indicator, but compress the distribution over a range of values closer to an optimal range. Changes to distributions will be checked by applying the Kolmogorov-Smirnov test.

02

Conditions studied

  • Exclusive Breast Feeding
  • Feeding Patterns
  • Stunting
  • Obesity, Childhood

Keywords

  • Stunting
  • Obesity
  • Lipid-based Nutrient Supplements (LNS)
  • Latin America
  • Child nutrition
  • Feeding practices
03

In context

Breast Feeding

1,081 studies on the registry are indexed under Breast Feeding; 217 are open to participants now.

This study's enrollment of 1,280 is above the median of 100 across 844 interventional studies indexed under Breast Feeding.

Browse Breast Feeding studies →

Lead sponsor

Inter-American Development Bank is the lead sponsor of 6 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Up to 3 Months
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Pregnant women in the third trimester or children 3 months of age
  • Living in the defined intervention areas
  • Children with no chronic diseases or congenital malformations
  • Not planning on moving far from the intervention area in the next 24 months

Exclusion criteria

Exclusion Criteria:

  • Children with any chronic disease or congenital malformation
  • Caretakers of the children plan on moving in the next 24 months
  • Children with severe acute malnutrition
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
1,280 participants (actual)

Study arms

  • Active comparator
    Standard Care+MNPs

    Participants will receive standard health care services provided by the Ministry of Health, including micronutrient powders (MNPs). Children 6 months old will receive 1 gram of powdered micronutrients for 60 days every 6 months until 24 months of age.

    Dietary Supplement: Micronutrient Powders

  • Experimental
    SPOON behavioral change strategy+SQ-LNS

    Participants will receive Small Quantity Lipid-based Supplements (SQ-LNS) from 6-24 months and a behavioral change to promote adequate infant and young child feeding practices and the use of SQ-LNS will be delivered to mothers or caregivers. The behavioral change strategy includes individual home-visits, group sessions, and community mobilization activities. SQ-LNS consists of a 20g nutrient supplement package to be consumed daily from 6-24 of age. SQ-LNS formulation does not include sugar.

    Behavioral: SPOON behavioral change strategy · Dietary Supplement: SQ-LNS

  • Experimental
    SPOON behavioral change strategy+MNPs

    Participants will receive micronutrient powders (MNPs) from 6-24 months and a behavioral change to promote adequate infant and young child feeding practices and the use of MNPs will be delivered to mothers or caregivers. The behavioral change strategy includes individual home-visits, group sessions, and community mobilization activities.

    Dietary Supplement: Micronutrient Powders · Behavioral: SPOON behavioral change strategy

Interventions

  • Dietary supplementMicronutrient Powders

    Micronutrient powders (5 nutrient formulation) are currently provided by the Guatemalan Ministry of Health to children between 6-24 months of age.

    Also known as: MNPs

  • BehavioralSPOON behavioral change strategy

    An innovative behavioral change strategy designed using ethnographic and marketing methods to promote adequate infant and young child feeding practices and the use of SQ-LNS. The strategy will be delivered to mothers or caregivers through individual home-visits, group sessions, and community mobilization activities.

  • Dietary supplementSQ-LNS

    SQ-LNS is a peanut-based ready to use home fortification product to improve diet quality in children 6-24 months of age. It includes peanuts and other ingredients such as vegetable fat, powdered milk and several micronutrients. The formulation designed for this study does not include sugar.

    Also known as: Smal Quantity Lipid-base Nutrient Supplements

06

What researchers measure

Primary outcomes

  1. Infant and young child feeding practices

    Set of indicators of infant and young child feeding practices obtained by interview to participant mothers or caregivers

    Time frame: Measured at baseline and after 24 months of intervention

  2. Height

    Height-for-age z score obtained by measuring the height of participant children

    Time frame: Measured at 6 and 24 months of age

  3. Weight gain rate

    Rate of weight gain from 0-24 months of age

    Time frame: Constructed from weight measurements at 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, and 24 months of age

  4. Hemoglobin

    Measurement of hemoglobin using a portable photometer

    Time frame: Measured at 6 and 24 months of age

  5. Prevalence of obesity in children

    Population estimation of obesity using Population estimation of obesity using Body Mass Index (BMI)

    Time frame: Measured at 6 and 24 months of age

  6. Prevalence of stunting

    Population estimation of stunting using height-for age \<-2 SD

    Time frame: Measured at 6 and 24 months of age

  7. Prevalence of anemia

    Population estimation of anemia using hemoglobin

    Time frame: Measured at 6 and 24 months of age

Secondary outcomes

  1. Adherence to Nutritional Supplement Regime

    Consumption of the nutritional supplement measured as the number of packets consumed in one month

    Time frame: Measured every months from 6 months of age until the end of the intervention

  2. Exclusive Breastfeeding

    Measured as an indicator of exclusive breastfeeding, self-reported by the mother of a child

    Time frame: Measured 24 months after the start of the intervention

07

Study locations

1 site
  • SPOON Guatemala
    Rabinal, Baja Verapaz, Guatemala
08

References and documents

Publications

  • Gonzalez Acero C, Martinez S, Perez-Exposito A, Winters S. Effect of an innovative behavioural change strategy and small-quantity lipid-based nutrient supplements on stunting and obesity in children in Baja Verapaz, Guatemala: protocol for a randomised control trial. BMJ Open. 2020 Jul 19;10(7):e035528. doi: 10.1136/bmjopen-2019-035528. Erratum In: BMJ Open. 2022 May 24;12(5):e035528corr1. doi: 10.1136/bmjopen-2019-035528corr1. PubMed 32690508 ↗

Individual participant data

Plan to share: Yes — Unidentified individual data will be shared among participating research institutions and made public 2 years after finalizing the study

Supporting information: Study protocol, Statistical analysis plan, Informed consent form, Analytic code

Time frame: 2 years after finalizing the study

Access criteria: Public

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Sep 2018 to primary completion in Nov 2021, 38 months.

Of 502 non-industry interventional studies with no phase under Breast Feeding, half reached primary completion within 12 months of starting (the median), counting those still running; a quarter within 6 and three quarters within 23. This study's 38 months is above that.

Counting every sponsor, half of 510 studies reached it within 12 months; a quarter within 6 and three quarters within 23.

How these figures are worked out, and which studies are left out of them.

Registered
Jan 8, 2018
First posted
Jan 16, 2018
StartActual
Sep 15, 2018
Primary completionActual
Nov 18, 2021
CompletionActual
Dec 18, 2021
Last update
Mar 9, 2022
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Mar 9, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03399617
Lead sponsor
Inter-American Development Bank
Collaborators
The PepsiCo Foundation, Fundazúcar
Responsible party
Sponsor
First posted
Jan 16, 2018
Start date
Sep 15, 2018
Primary completion
Nov 18, 2021
Completion
Dec 18, 2021
Last update
Mar 9, 2022

Study contacts

Sebastian Martinez
study director · IDB Evaluation Specialist

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Feb 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion